Back to top
more

CONMED (CNMD)

(Real Time Quote from BATS)

$72.21 USD

72.21
129,660

-1.75 (-2.37%)

Updated Aug 30, 2024 01:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (185 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Indrajit Bandyopadhyay headshot

MedTech Stocks' Earnings to Watch on Feb 2: BDX, DGX & CNMD

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how BDX, DGX and CNMD are likely to fare this time.

Here's Why You Should Retain CONMED (CNMD) Stock for Now

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

Why Is Conmed (CNMD) Up 6.8% Since Last Earnings Report?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MMSI vs. CNMD: Which Stock Should Value Investors Buy Now?

MMSI vs. CNMD: Which Stock Is the Better Value Option?

CONMED (CNMD) Down on In-Line Q3 Earnings & Lower 2022 View

CONMED's (CNMD) adjusted third-quarter earnings reflect strong segmental performance. Unfavorable currency movement hurt sales growth. Inflationary or supply chain challenges hurt gross margin.

Conmed (CNMD) Beats Q3 Earnings Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 2.67% and 2.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate LabCorp (LH) to Report a Decline in Earnings: What to Look Out for

LabCorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Conmed (CNMD) to Report a Decline in Earnings: What to Look Out for

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Reasons to Retain CONMED (CNMD) Stock in Your Portfolio

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

PDCO vs. CNMD: Which Stock Is the Better Value Option?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

CONMED (CNMD) Acquires Soft Tissue Implant Start-Up Biorez

CONMED (CNMD) acquires privately-held Biorez, Inc. for $85 million. The deal is set to boost CONMED's sports medicine portfolio with the addition of Biorez's proprietary BioBrace Implant technology.

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

CONMED (CNMD) Down on In-Line Q2 Earnings & Lower 2022 View

CONMED's (CNMD) adjusted second-quarter earnings reflect strong segmental performance. However, unfavorable currency movement hurt sales growth. Inflationary or supply chain challenges hurt gross margin.

Conmed (CNMD) Q2 Earnings Meet Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 0% and 1.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PDCO or CNMD: Which Is the Better Value Stock Right Now?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Conmed (CNMD) Reports Next Week: Wall Street Expects Earnings Growth

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to CONMED (CNMD) Stock Now

CONMED (CNMD) continues to gain momentum from a solid product portfolio and a strong General Surgery business. However, data security issues linger.

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

New Strong Sell Stocks for June 30th

WMT, EC, and CNMD have been added to the Zacks Rank #5 (Strong Sell) List on June 30, 2022.

Patterson Cos. (PDCO) Q4 Earnings and Revenues Beat Estimates

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 26.79% and 1.71%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for June 27th

CNMD, WMT, and CAH have been added to the Zacks Rank #5 (Strong Sell) List on June 27, 2022.

CONMED (CNMD) to Expand Orthopedic Portfolio With Buyout

CONMED's (CNMD) completion of In2Bones Global buyout will expand its orthopedic portfolio.

New Strong Sell Stocks for June 7th

CNMD, CL, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2022.

New Strong Sell Stocks for June 1st

CBAN, CNMD, and FNF have been added to the Zacks Rank #5 (Strong Sell) List on June 1, 2022.

PDCO or CNMD: Which Is the Better Value Stock Right Now?

PDCO vs. CNMD: Which Stock Is the Better Value Option?